New, clinically validated, natural solution for occasional anxiety introduced to the United States*
GREEN BAY, WI (Jan 20, 2012) – For the first time, an exclusive lavender (Lavandula angustifolia) essential oil indicated for occasional anxiety is being introduced to the United States. This clinically validated oil – Lavela WS 1265™ is available through the practitioner exclusive brand – Integrative Therapeutics™.
Indicated for occasional anxiety, Lavela WS 1265 (referred to as Silexan™ in published research), has been shown to promote relaxation and calm nervousness with safety and efficacy, as demonstrated in controlled trials published in peer-reviewed medical journals.*1,2 Lavela WS 1265 offers relief without the side effects commonly seen in other options. Taken just once a day, this gentle, yet powerful, essential oil is non-habit-forming and well-tolerated. Clinical trials and a comparative analysis suggest that the effects of Lavela WS 1265 compare favorably to other options.*1-3
Integrative Therapeutics adds this product to a line-up of other clinically-validated natural products, including ViraClear EPs 7630™.
###
Integrative Therapeutics, LLC manufactures and distributes proprietary, natural supplements exclusively to medical professionals. Its manufacturing facility meets stringent quality standards and is an FDA-registered drug establishment. In addition to providing superior quality products, Integrative Therapeutics offers a variety of practitioner resources, including educational events. Find out more at http://www.integrativeinc.com
Media Contact: Cindy Zuege, Marketing Brand Manager
Integrative Therapeutics, LLC
920.469.1313 x63842 [email protected]
1. Kasper S, Gastpar M, Müller WE, et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol 2010 Sep;25(5):277-87.
2. Woelk H, Schälfke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine 2010;17:94–99.
3. Hidalgo RB, Tupler LA, Davidson JR. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol 2007;21:864–72.
